Project Details
Description
A Phase 2A study of ALXN1007 in subjects with newly diagnosed acute graft-versus-host disease involving the lower gastrointestinal tract
| Status | Finished |
|---|---|
| Effective start/end date | 3/4/14 → 3/30/18 |
Funding
- ALEXION PHARMACEUTICALS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.